{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:29:19Z","timestamp":1782458959355,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015077","name":"Jagiellonian University Medical College Faculty of Medicine","doi-asserted-by":"publisher","award":["N41\/DBS\/000682"],"award-info":[{"award-number":["N41\/DBS\/000682"]}],"id":[{"id":"10.13039\/100015077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.thromres.2024.109086","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T06:53:00Z","timestamp":1719989580000},"page":"109086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Elevated plasma factor XI is associated with postthrombotic syndrome"],"prefix":"10.1016","volume":"241","author":[{"given":"Konrad","family":"St\u0119pie\u0144","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Siudut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Zalewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.109086_bb0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11239-015-1312-5","article-title":"Guidance for the prevention and treatment of the post-thrombotic syndrome","volume":"41","author":"Kahn","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2024.109086_bb0010","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/j.1538-7836.2005.01648.x","article-title":"The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease","volume":"3","author":"Stain","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/ATVBAHA.108.162289","article-title":"Mechanisms of venous thrombosis and resolution","volume":"28","author":"Wakefield","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2024.109086_bb0020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/a-2039-3388","article-title":"Performance and head-to-head comparison of three clinical models to predict occurrence of postthrombotic syndrome: a validation study","volume":"123","author":"Pradier","year":"2023","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jth.12106","article-title":"Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency","volume":"11","author":"Galanaud","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0030","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/jth.13264","article-title":"Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome","volume":"14","author":"Siudut","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.thromres.2015.12.014","article-title":"The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: a population-based, cross-sectional study","volume":"138","author":"Wik","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.109086_bb0040","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM200003093421004","article-title":"High levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"342","author":"Meijers","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.109086_bb0045","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jtha.2023.02.031","article-title":"Predictive value for increased activated factor XI activity in acute venous thromboembolism","volume":"21","author":"Nagy","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0050","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.3390\/jcm12154890","article-title":"Persistently high levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"12","author":"Spiezia","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2024.109086_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.thromres.2022.11.023","article-title":"Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism","volume":"221","author":"Iding","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.109086_bb0060","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/jth.15777","article-title":"Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis","volume":"20","author":"Jordan","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0065","first-page":"16604","article-title":"D-dimers in diagnosis and prevention of venous thrombosis: recent advances and their practical implications","volume":"133","author":"Cosmi","year":"2023","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2024.109086_bb0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2024.109086_bb0075","first-page":"16421","article-title":"Cancer-associated thrombosis: comparison of characteristics, treatment, and outcomes in oncologic and nononcologic patients followed by a pulmonary embolism response team","volume":"133","author":"Pietrasik","year":"2023","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2024.109086_bb0080","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3390\/jcm9072018","article-title":"Delayed thrombin generation is associated with minor bleedings in venous thromboembolism patients on rivaroxaban: usefulness of calibrated automated thrombography","volume":"9","author":"Zalewski","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2024.109086_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107153","article-title":"Effect of high-dose statin therapy on coagulation factors: lowering of factor XI as a modifier of fibrin clot properties in coronary artery disease","volume":"149","author":"St\u0119pie\u0144","year":"2023","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.thromres.2024.109086_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-023-02901-y","article-title":"Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism","author":"St\u0119pie\u0144","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2024.109086_bb0095","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH05-03-0146","article-title":"The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study","volume":"94","author":"Roumen-Klappe","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11239-019-01914-w","article-title":"Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study","volume":"48","author":"Polak","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2024.109086_bb0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The post-thrombotic syndrome","volume":"2016","author":"Kahn","year":"2016","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.thromres.2024.109086_bb0110","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/s-0040-1710013","article-title":"Role of factor XIa and plasma kallikrein in arterial and venous thrombosis","volume":"120","author":"Visser","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0115","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1055\/s-0042-1742366","article-title":"Active FXI can independently predict ischemic stroke in anticoagulated atrial fibrillation patients: a cohort study","volume":"122","author":"Z\u0105bczyk","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0120","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12933-023-01905-5","article-title":"Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study","volume":"22","author":"Paszek","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.thromres.2024.109086_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14196","article-title":"Elevated factor XI is associated with recurrent left ventricular thrombus of unknown origin","author":"Zandecki","year":"2024","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.thromres.2024.109086_bb0130","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jvs.2008.12.017","article-title":"Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls","volume":"49","author":"Darvall","year":"2009","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.thromres.2024.109086_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00015555210317","article-title":"Causes and effects of the chronic inflammation in venous leg ulcers","volume":"210","author":"Agren","year":"2000","journal-title":"Acta Derm. Venereol. Suppl. (Stockh)."},{"key":"10.1016\/j.thromres.2024.109086_bb0140","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1182\/blood-2003-10-3422","article-title":"Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism","volume":"103","author":"Eichinger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.109086_bb0145","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1055\/s-0037-1614902","article-title":"Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation","volume":"82","author":"Bouma","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0150","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jth.12216","article-title":"Insights into thrombin activatable fibrinolysis inhibitor function and regulation","volume":"11","author":"Foley","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0155","doi-asserted-by":"crossref","first-page":"9761","DOI":"10.1038\/s41598-022-13174-5","article-title":"Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis","volume":"12","author":"Pallares Robles","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2024.109086_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102276","article-title":"Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia","volume":"8","author":"Kohs","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109086_bb0165","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1189\/jlb.0411182","article-title":"Activated factor XI inhibits chemotaxis of polymorphonuclear leukocytes","volume":"90","author":"Itakura","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.thromres.2024.109086_bb0170","first-page":"16288","article-title":"How to optimize the prevention of post-thrombotic syndrome: recent advances","volume":"132","author":"Iding","year":"2022","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2024.109086_bb0175","first-page":"16543","article-title":"How to treat isolated distal deep vein thrombosis","volume":"133","author":"Potere","year":"2023","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2024.109086_bb0180","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2105872","article-title":"Abelacimab for prevention of venous thromboembolism","volume":"385","author":"Verhamme","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.109086_bb0185","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa2113194","article-title":"Milvexian for the prevention of venous thromboembolism","volume":"385","author":"Weitz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.109086_bb0190","doi-asserted-by":"crossref","first-page":"334","DOI":"10.20452\/pamw.961","article-title":"Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy","volume":"120","author":"Zabczyk","year":"2010","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.thromres.2024.109086_bb0195","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V85.6.1517.bloodjournal8561517","article-title":"Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor","volume":"85","author":"Wuillemin","year":"1995","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T10:42:00Z","timestamp":1728297720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824002184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":39,"alternative-id":["S0049384824002184"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109086","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated plasma factor XI is associated with postthrombotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109086"}}